Capricor Therapeutics, Inc. Made Headway

Wed, Apr 08, 2020 at 05:30 PM

Capricor Therapeutics, Inc. (CAPR:NASDAQ) shot up at $1.78, representing a gain of 50.8%. The stock appeared on our News Catalysts scanner on Mon 06 Apr 20 at 05:31 PM in the 'MISCELLANEOUS' category. From Tue 24 Mar 20, the stock recorded 40.00% Up Days and 27.27% Green Days

The stock spiked on Wed 25 Mar 20 at $2.25 with a volume of 5M+.

About Capricor Therapeutics, Inc. (CAPR:NASDAQ)

Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.

Top 10 Gainers:

BIOLASE, Inc. (BIOL:NASDAQ), 249.57%
Moleculin Biotech, Inc. (MBRX:NASDAQ), 125.7%
Ellington Financial Inc. (EFC:NYSE), 74.71%
Moxian, Inc. (MOXC:NASDAQ), 64.15%
Intelsat S.A. (I:NYSE), 57.14%
Exantas Capital Corp. (XAN:NYSE), 51.78%
Capricor Therapeutics, Inc. (CAPR:NASDAQ), 50.85%
Ellington Residential Mortgage REIT (EARN:NYSE), 50.37%
New York Mortgage Trust, Inc. (NYMT:NASDAQ), 49.25%
Forestar Group Inc. (FOR:NYSE), 47.06%